Literature DB >> 11347890

Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes.

T Gutsmann1, N Haberer, S F Carroll, U Seydel, A Wiese.   

Abstract

The mechanism of interaction of the lipopolysaccharide (LPS)-binding protein, LBP, with differently composed symmetric and asymmetric planar lipid bilayers was investigated in electrical measurements (membrane current, potential, capacitance). From a change of the inner membrane potential difference, binding of LBP to membranes was deduced. After addition of LBP to one side of the membrane, binding of anti-LBP antibodies and LPS to LBP on both sides of the bilayer was observed. Effects resulting from an interaction of anti-LBP antiserum with membrane-bound LBP depend on the side of addition of the antiserum, indicating a directed intercalation of LBP into the membrane. Addition of LPS to the same side as LBP may induce a change of the conformation of LBP or its orientation in the membrane. Based on these observations, we propose that LBP intercalates in a directed orientation into negatively-charged membranes and assumes a transmembrane configuration. Moreover, pre-incubated complexes of LPS and LBP do not interact with membranes. These experiments show that reconstituted planar membranes are a suitable tool for investigations of the interaction of non pore-forming proteins that are involved in signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11347890     DOI: 10.1515/BC.2001.052

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  8 in total

1.  Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells.

Authors:  T Gutsmann; M Müller; S F Carroll; R C MacKenzie; A Wiese; U Seydel
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Modeling the electrostatic potential of asymmetric lipopolysaccharide membranes: the MEMPOT algorithm implemented in DelPhi.

Authors:  Roberta P Dias; Lin Lin; Thereza A Soares; Emil Alexov
Journal:  J Comput Chem       Date:  2014-05-06       Impact factor: 3.376

3.  Interaction of lipopolysaccharide and phospholipid in mixed membranes: solid-state 31P-NMR spectroscopic and microscopic investigations.

Authors:  Kaoru Nomura; Takehiko Inaba; Kenichi Morigaki; Klaus Brandenburg; Ulrich Seydel; Shoichi Kusumoto
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

4.  LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction.

Authors:  Rebecca M Minter; Xiaoming Bi; Gal Ben-Josef; Tianyi Wang; Bin Hu; Saman Arbabi; Mark R Hemmila; Stewart C Wang; Daniel G Remick; Grace L Su
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-23       Impact factor: 4.052

5.  Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis.

Authors:  Jörg Andrä; Jörg Howe; Patrick Garidel; Manfred Rössle; Walter Richter; José Leiva-León; Ignacio Moriyon; Rainer Bartels; Thomas Gutsmann; Klaus Brandenburg
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

6.  3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and Toll-like receptor signaling in human oral keratinocytes.

Authors:  Pei-Hui Ding; Richard P Darveau; Cun-Yu Wang; Lijian Jin
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

7.  A Single Step in vitro Bioassay Mimicking TLR4-LPS Pathway and the Role of MD2 and CD14 Coreceptors.

Authors:  Pramod Jagtap; Puja Prasad; Abhishek Pateria; Sachin D Deshmukh; Shalini Gupta
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

Review 8.  Shedding light on the structural properties of lipid bilayers using molecular dynamics simulation: a review study.

Authors:  Sajad Moradi; Amin Nowroozi; Mohsen Shahlaei
Journal:  RSC Adv       Date:  2019-02-06       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.